High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine Robert C. GaverGeorge Deeb Original Articles Pages: 201 - 206
A radioimmunoassay procedure for tallysomycin S10b in human plasma and urine Robert C. GaverClarence W. DixonRobert D. Smyth Original Articles Pages: 207 - 210
Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue Steven D. AverbuchRonald E. ClawsonRonald L. Felsted Original Articles Pages: 211 - 217
Disposition and metabolism of the antitumor glycoside phyllanthoside in mouse and beagle dog David J. MooreGarth Powis Original Articles Pages: 218 - 222
Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats Roger RahmaniFrancoise GuéritteJacques Barbet Original Articles Pages: 223 - 228
Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma Gary G. MeadowsRokia M. AbdallahJean R. Starkey Original Articles Pages: 229 - 236
Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma Magnus H. O. BerneBengt G. GustavssonRoland Frösing Original Articles Pages: 237 - 242
The mouse as a model for predicting the myelosuppressive effects of anticancer drugs John E. SchurigAlexander P. FlorczykWilliam T. Bradner Original Articles Pages: 243 - 246
Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and-resistant P388 cells D. G. StreeterJ. S. JohlJ. H. Peters Original Articles Pages: 247 - 252
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino]-4-acridinecarboxamide in rabbits James W. PaxtonJeffrey L. Jurlina Original Articles Pages: 253 - 256
Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG) V. Erdélyi-TóthS. Kerpel-FroniusS. Eckhardt Original Articles Pages: 257 - 263
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG) S. Kerpel-FroniusV. Erdélyi-TóthS. Eckhardt Original Articles Pages: 264 - 268
In vivo toxicity of phenothiazines to cells of a transplantable tumor Shirley Lehnert Original Articles Pages: 269 - 272
Activation of 2′,5′-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: Dependence of biological effect on administration route Michel G. RosenblumAdan RisoJordan U. Gutterman Original Articles Pages: 273 - 276
Flow cytometric analysis of marrow cell kinetics in children treated with high-dose MTX and CF rescue Masahito TsurusawaKuniaki SasakiTakeo Fujimoto Original Articles Pages: 277 - 281
An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting John F. KesslerDavid S. AlbertsEarl A. Surwit Original Articles Pages: 282 - 286
Clinical and clinical pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728) James A. StewartCynthia C. AckerlyIrwin H. Krakoff Original Articles Pages: 287 - 291
Clinical pharmacology of intracarotid etoposide Niramol SavarajLynn G. FeunTi Li Loo Original Articles Pages: 292 - 294
Low dose oral administration of 4-demethoxy-daunorubicin (idarubicin) in advanced cancer patients Franco PannutiCarlo M. CamaggiMaria A. Pacciarini Original Articles Pages: 295 - 299
Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis Claude ArdietBrigitte TranchandThierry Philip Original Articles Pages: 300 - 305
Acute neurological toxicity of intrathecal cytosine arabinoside S. Michael CrawfordGordon J. S. RustinKenneth D. Bagshawe Original Articles Pages: 306 - 307